Non-interventional Study (NIS) to provide Information about Infliximab-Pen for Subcutaneous Infliximab Application (product: Remsima® 120 mg)
Latest Information Update: 30 Nov 2020
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 30 Nov 2020 New trial record